PESHAWAR: Khyber Medical University has finalised arrangements for conducting clinical trials of an indigenously developed herbal medicine aimed at treating cutaneous leishmaniasis (CL), a painful and disfiguring skin disease that has seen a significant rise in Khyber Pakhtunkhwa.

Preparations for the final testing of this herbal ointment, developed by two scientists from KP, have been completed, disclosed Dr Khalid Rehman, director public health KMU.

“The clinical trial, scheduled to last around six months, will involve three groups of patients undergoing different treatment procedures to evaluate the medicines effectiveness,” Dr Rehman informed this news agency.

“The treatment modules include standard practice of administering glucantime injections, photodynamic therapy (PDT) in collaboration with Irnum Hospital and application of the locally prepared herbal medicine,” he said.

Dr Rehman said trials would be held at a hotspot of CL infection area, preferably Malakand district, to expand its coverage scope to Bajaur and Mohmand districts, where a large number of CL cases were reported.

Published in Dawn, January 13th, 2025

Opinion

Editorial

Ill omens
12 Feb, 2025

Ill omens

IT sometimes appears as if those struggling for an independent judiciary have needlessly burdened themselves with...
Sunken dreams
12 Feb, 2025

Sunken dreams

ANOTHER tragedy has struck Pakistani migrants seeking a better future. A boat capsizing off the Libyan coast has ...
Hate in India
12 Feb, 2025

Hate in India

HISTORY shows that rulers use hate speech to provoke hate crimes and ‘othering’ among communities. Indian Prime...
IMF scrutiny
Updated 11 Feb, 2025

IMF scrutiny

Strengthening foundations of the economic superstructure will help make the economy competitive and boost growth.
Shadow voices
11 Feb, 2025

Shadow voices

OVER the weekend, another ‘open letter’ addressed to the army chief and attributed to former prime minister ...
Paradise at a premium
11 Feb, 2025

Paradise at a premium

PAKISTAN’S recent triumph at the New York Travel and Adventure Show 2025, winning the Best Partner Pavilion Award,...